Biometrical Journal

Article	Citations
Missing data: A statistical framework for practice	93
Making apples from oranges: Comparing noncollapsible effect estimators and their standard errors after adjustment for different covariate sets	78
Nowcasting the COVID‐19 pandemic in Bavaria	54
An ensemble approach to short‐term forecast of COVID‐19 intensive care occupancy in Italian regions	27
Stability of clinical prediction models developed using statistical or machine learning methods	27
Nowcasting fatal COVID‐19 infections on a regional level in Germany	21
A bias‐corrected meta‐analysis model for combining, studies of different types and quality	21
Survival analysis for AdVerse events with VarYing follow‐up times (SAVVY): Rationale and statistical concept of a meta‐analytic study	15
On the logic of collapsibility for causal effect measures	15
Phases of methodological research in biostatistics—Building the evidence base for new methods	14
A comparison of methods for analysing multiple outcome measures in randomised controlled trials using a simulation study	14
A product‐limit estimator of the conditional survival function when cure status is partially known	13
A statistical model for the dynamics of COVID‐19 infections and their case detection ratio in 2020	13
Multiple imputation methods for handling missing values in longitudinal studies with sampling weights: Comparison of methods implemented in Stata	13
Sample size and power considerations for cluster randomized trials with count outcomes subject to right truncation	13
Bayesian regularization for flexible baseline hazard functions in Cox survival models	12
Impact of unequal cluster sizes for GEE analyses of stepped wedge cluster randomized trials with binary outcomes	12
Accurate error control in high‐dimensional association testing using conditional false discovery rates	12
An adjusted coefficient of determination (R2) for generalized linear mixed models in one go	12
Two‐dimensional P‐spline smoothing for spatial analysis of plant breeding trials	11
gBOIN‐ET: The generalized Bayesian optimal interval design for optimal dose‐finding accounting for ordinal graded efficacy and toxicity in early clinical trials	10
Categories, components, and techniques in a modular construction of basket trials for application and further research	10
Pitfalls and potentials in simulation studies: Questionable research practices in comparative simulation studies allow for spurious claims of superiority of any method	9
Time‐dependent ROC curve estimation for interval‐censored data	8
Generalized pairwise comparisons for censored data: An overview	8

A joint frailty‐copula model for meta‐analytic validation of failure time surrogate endpoints in clinical trials	8
Power considerations for generalized estimating equations analyses of four‐level cluster randomized trials	7
Bounds for the weight of external data in shrinkage estimation	7
Meta‐analysis of diagnostic accuracy studies with multiple thresholds: Comparison of different approaches	7
Understanding disparities in cancer prognosis: An extension of mediation analysis to the relative survival framework	7
Use of correlated scrambling variables in quantitative randomized response technique	7
A mechanistic spatio‐temporal modeling of COVID‐19 data	7
Sample size calculation for two‐arm trials with time‐to‐event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions	7
Correct and logical causal inference for binary and time‐to‐event outcomes in randomized controlled trials	7
Quantile modeling through multivariate log‐normal/independent linear regression models with application to newborn data	7
Frequentist performances of Bayesian prediction intervals for random‐effects meta‐analysis	6
Multivariate linear mixed models with censored and nonignorable missing outcomes, with application to AIDS studies	6
Using independent cross‐sectional survey data to predict post‐migration health trajectories among refugees by estimating transition probabilities and their variances	6
Impact of the matching algorithm on the treatment effect estimate: A neutral comparison study	6
Random‐effects meta‐analysis models for the odds ratio in the case of rare events under different data‐generating models: A simulation study	6
Bayesian time‐varying autoregressive models of COVID‐19 epidemics	6
Growth dynamics and heritability for plant high‐throughput phenotyping studies using hierarchical functional data analysis	6
Power and sample size for random coefficient regression models in randomized experiments with monotone missing data	6
Against the “one method fits all data sets” philosophy for comparison studies in methodological research	6
A parametric quantile regression approach for modelling zero‐or‐one inflated double bounded data	6
Maximin design of cluster randomized trials with heterogeneous costs and variances	6
On the role of benchmarking data sets and simulations in method comparison studies	6
Simulating longitudinal data from marginal structural models using the additive hazard model	5
Improving sandwich variance estimation for marginal Cox analysis of cluster randomized trials	5
A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons	5
Comparing linear discriminant analysis and supervised learning algorithms for binary classification—A method comparison study	5
The nonparametric Behrens–Fisher problem in partially complete clustered data	5
Approximate maximum likelihood estimation for logistic regression with covariate measurement error	5
Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events	5
Model selection characteristics when using MCP‐Mod for dose–response gene expression data	5
Robust group sequential designs for trials with survival endpoints and delayed response	5
Combining biomarkers by maximizing the true positive rate for a fixed false positive rate	5
Hypothesis testing in multivariate normal models with block circular covariance structures	5
Bayesian variable selection for the Cox regression model with spatially varying coefficients with applications to Louisiana respiratory cancer data	5
Misspecified modeling of subsequent waves during COVID‐19 outbreak: A change‐point growth model	4
Enhancing estimation methods for integrating probability and nonprobability survey samples with machine‐learning techniques. An application to a Survey on the impact of the COVID‐19 pandemic in Spain	4
A gentle tutorial on accelerated parameter and confidence interval estimation for hidden Markov models using Template Model Builder	4
Using mortality to predict incidence for rare and lethal cancers in very small areas	4
Individual risk prediction: Comparing random forests with Cox proportional‐hazards model by a simulation study	4
High‐dimensional feature selection in competing risks modeling: A stable approach using a split‐and‐merge ensemble algorithm	4
New methods for the additive hazards model with the informatively interval‐censored failure time data	4
Joint estimation of case fatality rate of COVID‐19 and power of quarantine strategy performed in Wuhan, China	4
Analyzing longitudinal clustered count data with zero inflation: Marginal modeling using the Conway–Maxwell–Poisson distribution	4
A spatial model to jointly analyze self‐reported survey data of COVID‐19 symptoms and official COVID‐19 incidence data	4
Sensitivity and identification quantification by a relative latent model complexity perturbation in Bayesian meta‐analysis	4
Causal inference in case of near‐violation of positivity: comparison of methods	4
Clinical risk prediction models and informative cluster size: Assessing the performance of a suicide risk prediction algorithm	4
Bayesian analysis of one‐inflated models for elusive population size estimation	4
New weighting methods when cases are only a subset of events in a nested case‐control study	4
An iterative method to protect the type I error rate in bioequivalence studies under two‐stage adaptive 2×2 crossover designs	4

Comparison of normal distribution–based and nonparametric decision limits on the GH‐2000 score for detecting growth hormone misuse (doping) in sport	4
Missing data imputation in clinical trials using recurrent neural network facilitated by clustering and oversampling	4
Correcting the bias of the net benefit estimator due to right‐censored observations	4
Modeling time‐varying recruitment rates in multicenter clinical trials	4
Sample size optimization and initial allocation of the significance levels in group sequential trials with multiple endpoints	4
A note of feature screening via a rank‐based coefficient of correlation	4
The modified fuzzy mortality model based on the algebra of ordered fuzzy numbers	4
On optimal two‐stage testing of multiple mediators	4
M‐quantile regression shrinkage and selection via the Lasso and Elastic Net to assess the effect of meteorology and traffic on air quality	4
Improved generalized raking estimators to address dependent covariate and failure‐time outcome error	4
Toward a standardized evaluation of imputation methodology	4
Two sensitive characteristics and their overlap with two questions per card	3
Sequential change point detection for high‐dimensional data using nonconvex penalized quantile regression	3
Optimal dose‐finding for efficacy–safety models	3
Randomized ‐values for multiple testing and their application in replicability analysis	3
A flexible joint model for multiple longitudinal biomarkers and a time‐to‐event outcome: With applications to dynamic prediction using highly correlated biomarkers	3
Functional modeling of recurrent events on time‐to‐event processes	3
Cox regression analysis for distorted covariates with an unknown distortion function	3
Statistical inference for the difference between two maximized Youden indices obtained from correlated biomarkers	3
Improving adaptive seamless designs through Bayesian optimization	3
Restricted survival benefit with right‐censored data	3
On the relevance of prognostic information for clinical trials: A theoretical quantification	3
A comparative study of in vitro dose–response estimation under extreme observations	3
A multilevel structural equation model for assessing a drug effect on a patient‐reported outcome measure in on‐demand medication data	3
An approximate Bayesian approach for estimation of the instantaneous reproduction number under misreported epidemic data	3
Correcting for heterogeneity and non‐comparability bias in multicenter clinical trials with a rescaled random‐effect excess hazard model	3
Multiple two‐sample testing under arbitrary covariance dependency with an application in imaging mass spectrometry	3
A new robust Bayesian small area estimation via ‐stable model for estimating the proportion of athletic students in California	3
Asymptotic‐based bootstrap approach for matched pairs with missingness in a single arm	3
Sample size determination for comparing accuracies between two diagnostic tests under a paired design	3
A comparison of full model specification and backward elimination of potential confounders when estimating marginal and conditional causal effects on binary outcomes from observational data	3
Subclassification estimation of the weighted average treatment effect	3
Modeling and computation of multistep batch testing for infectious diseases	3
Semiparametric marginal methods for clustered data adjusting for informative cluster size with nonignorable zeros	3
Estimating the optimal population upper bound for scan methods in retrospective disease surveillance	3
Optimal dynamic treatment regime estimation using information extraction from unstructured clinical text	3
On the equivalence of one‐inflated zero‐truncated and zero‐truncated one‐inflated count data likelihoods	3
TITE‐gBOIN‐ET: Time‐to‐event generalized Bayesian optimal interval design to accelerate dose‐finding accounting for ordinal graded efficacy and toxicity outcomes	3
A Q‐Q plot aids interpretation of the false discovery rate	3
A new method for clustered survival data: Estimation of treatment effect heterogeneity and variable selection	3
Discussion on ‘Correct and logical causal inference for binary and time‐to‐event outcomes in randomized controlled trials'	3
Isolating cost drivers in interstitial lung disease treatment using nonparametric Bayesian methods	2
Explaining the optimistic performance evaluation of newly proposed methods: A cross‐design validation experiment	2
On the choice of timescale for other cause mortality in a competing risk setting using flexible parametric survival models	2
Variable selection in linear regression models: Choosing the best subset is not always the best choice	2
Simple confidence interval and region formulas for comparing diagnostic likelihood ratios under a paired design	2
Comparing algorithms for characterizing treatment effect heterogeneity in randomized trials	2
Gene–environment interaction identification via penalized robust divergence	2
Designing multicenter individually randomized group treatment trials	2
D‐optimal designs of mean‐covariance models for longitudinal data	2
Expected life years compared to the general population	2
Quantifying uncertainty in method of moments estimates of the heterogeneity variance in random effects meta‐analysis	2
A quantile‐slicing approach for sufficient dimension reduction with censored responses	2
Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy	2
Bayesian design for minimizing prediction uncertainty in bivariate spatial responses with applications to air quality monitoring	2
Flexible cloglog links for binomial regression models as an alternative for imbalanced medical data	2
Comparison of statistical models to predict age‐standardized cancer incidence in Switzerland	2
Joint control of consensus and evidence in Bayesian design of clinical trials	2
Confident identification of subgroups from SNP testing in RCTs with binary outcomes	2
A hidden Markov model for continuous longitudinal data with missing responses and dropout	2
Type I multivariate zero‐inflated COM–Poisson regression model	2
A joint Bayesian framework for missing data and measurement error using integrated nested Laplace approximations	2
Statistical review of animal trials—A guideline	2
Regression‐based heterogeneity analysis to identify overlapping subgroup structure in high‐dimensional data	2
Confirmatory adaptive group sequential designs for single‐arm phase II studies with multiple time‐to‐event endpoints	2
	2
Mean residual life cure models for right‐censored data with and without length‐biased sampling	2
Monte Carlo sensitivity analysis for unmeasured confounding in dynamic treatment regimes	2
Semiparametric empirical likelihood inference for abundance from one‐inflated capture–recapture data	2
Robust probit linear mixed models for longitudinal binary data	2
Blinded sample size recalculation in adaptive enrichment designs	2
Rectangular tolerance regions and multivariate normal reference regions in laboratory medicine	2
Bayesian estimation of two‐part joint models for a longitudinal semicontinuous biomarker and a terminal event with INLA: Interests for cancer clinical trial evaluation	2
Assurance in vaccine efficacy clinical trial design based on immunological responses	2
Exact simultaneous confidence intervals for logical selection of a biomarker cut‐point	2
A neutral comparison of statistical methods for analyzing longitudinally measured ordinal outcomes in rare diseases	2
A unified framework for weighted parametric group sequential design	2
Synthesizing secondary data into survival analysis to improve estimation efficiency	2
Penalized joint generalized estimating equations for longitudinal binary data	2
Clustered restricted mean survival time regression	2

Inverse problem approach to regularized regression models with application to predicting recovery after stroke

2